PE firm picks up model provider Taconic
Backed by a private equity investment, Taconic Biosciences is focusing on its growth strategy, with plans to add capacity, pursue acquisitions, and develop new products, says the company’s new CEO.
Archives for February 11, 2019
PCI continues expansion with Rockford bottling line
PCI updates packaging operations and bottling equipment at its Rockford site, in a multi-million dollar growth initiative to meet customer demand.
Dutch university funded to manufacture own version of €170k per year med
Amsterdam UMC given €5m to produce an affordable version of Leadiant’s CDCA, after price increases meant the drug was no longer covered by insurance.
Ncardia speeds up drug discovery with iPSC platform
Preclinical CRO Ncardia’s drug screening platform enables researchers to access human disease-relevant biology for drug discovery.
Sharp mitigates clinical supply overproduction with IRT investment
Sharp invests $650,000 in its IRT solution to ensure proper supply allocations to support clinical trials and reduce costly overproduction for sponsors.
Pfizer recalls valsartan drug after possible carcinogen present
Pfizer Japan recalls its high blood pressure drug containing the API valsartan after possible carcinogenic impurities were found.
Icon introduces new drug safety reporting solution
Icon’s new drug safety reporting platform automates complex processes to ensure compliance in the ‘ever-changing’ regulatory environment, says VP.
Mastering clinical drug distribution in an era of advanced therapies and global trials
Paid for and content provided by Marken
The composition of clinical trial pipelines is changing quickly as the rise of advanced therapies adds another layer to the multi-decade shift from small molecules to biologics. This change is fueling once-unimaginable advances in the treatment of...